Drug
PrabotulinumtoxinA
PrabotulinumtoxinA is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
2
50%
Ph not_applicable
1
25%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Active, not recruiting2
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
active_not_recruiting250%
completed125%
unknown125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
NCT07452510
active_not_recruiting
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
NCT05481931
completedearly_phase_1
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
NCT05129319
unknownearly_phase_1
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
NCT04715048
Clinical Trials (4)
Showing 4 of 4 trials
NCT07452510Not Applicable
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
NCT05481931
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
NCT05129319Early Phase 1
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
NCT04715048Early Phase 1
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4